AbCellera Biologics Inc.ABCLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P11
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -8.97% |
| Q3 2025 | 40.33% |
| Q2 2025 | -7.73% |
| Q1 2025 | -7.77% |
| Q4 2024 | 12.47% |
| Q3 2024 | 0.10% |
| Q2 2024 | 4.17% |
| Q1 2024 | -19.20% |
| Q4 2023 | 28.23% |
| Q3 2023 | 3.96% |
| Q2 2023 | -30.72% |
| Q1 2023 | 86.39% |
| Q4 2022 | 6.26% |
| Q3 2022 | -0.39% |
| Q2 2022 | 1.21% |
| Q1 2022 | 53.21% |
| Q4 2021 | -1.38% |
| Q3 2021 | 15.98% |
| Q2 2021 | 21.81% |
| Q1 2021 | 43.02% |
| Q4 2020 | 15.23% |
| Q3 2020 | -18.03% |
| Q2 2020 | 122.05% |
| Q1 2020 | 24.46% |
| Q4 2019 | 18.93% |
| Q3 2019 | 38.33% |
| Q2 2019 | -0.00% |
| Q1 2019 | 0.00% |